OpenMed-ZeroShot-NER-Oncology-Base-220M

Oncology-focused model for **cancer genetics**, capturing genes, variants, and cellular processes in tumor biology contexts.Useful for **cancer pathway curation**, **driver gene analysis**, and **precision oncology literature mining**. OpenMed ZeroShot NER is an advanced, domain-adapted Named Entity Recognition (NER) model designed specifically for medical, biomedical, and clinical text mining. Leveraging state-of-the-art zero-shot learning, this model empowers researchers, clinicians, and data scientists to extract expert-level biomedical entities—such as diseases, chemicals, genes, species, and clinical findings—directly from unstructured text, without the need for task-specific retraining. Built on the robust GLiNER architecture and fine-tuned on curated biomedical corpora, OpenMed ZeroShot NER delivers high-precision entity recognition for critical healthcare and life sciences applications. Its zero-shot capability means you can flexibly define and extract any entity type relevant to your workflow, from standard biomedical categories to custom clinical concepts, supporting rapid adaptation to new research domains and regulatory requirements.

번역 준비 중입니다. 원문을 표시합니다.